# Cancer Genome & Epigenetics

> **NIH NIH P30** · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · 2024 · $56,413

## Abstract

The overall goals of the Cancer Genome & Epigenetics (CGE) Program (formerly Tumor Initiation and Maintenance Program) are to identify the cells that give rise to tumors and the signals that allow these cells to expand uncontrollably, and to use this information to develop more effective approaches to treating human cancer.

## Key facts

- **NIH application ID:** 11092500
- **Project number:** 5P30CA030199-43
- **Recipient organization:** SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- **Principal Investigator:** PETER D. ADAMS
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $56,413
- **Award type:** 5
- **Project period:** 2024-05-01 → 2025-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11092500

## Citation

> US National Institutes of Health, RePORTER application 11092500, Cancer Genome & Epigenetics (5P30CA030199-43). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11092500. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*